养血祛风方联合止痒方外洗治疗血液透析患者血虚风燥型皮肤瘙痒临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R758.3+1

基金项目:


Clinical Study on Yangxue Qufeng Prescription Combined with Zhiyang Prescription for External Washing in Treating Skin Itching of Blood Deficiency and Wind-Dryness Type in Hemodialysis Patients
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察养血祛风方联合止痒方外洗治疗血液透析患者血虚风燥型皮肤瘙痒的临床疗效。方法: 选择2023年3—12月温岭市中医院收治的104例血液透析并发血虚风燥型皮肤瘙痒患者,按随机数字表法分为 治疗组和对照组各52例。对照组给予氯雷他定治疗,治疗组在对照组基础上给予养血祛风方联合止痒方外洗 治疗,2组连续治疗4周。比较2组治疗前后中医证候积分、改良Duo's瘙痒评分、皮肤病生活质量指数量 表(DLQI) 评分、炎症因子水平;比较2组临床疗效、不良反应发生率及疾病复发率。结果:治疗组总有效率 94.23%(49/52),高于对照组80.77%(42/52)(P<0.05)。治疗后,2组改良Duo's瘙痒评分、中医证候积分、 DLQI评分及血清C-反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6) 水平均较治疗前降 低(P<0.05),且治疗组改良Duo's瘙痒评分、中医证候积分、DLQI评分及血清各炎症因子低于对照组(P< 0.05)。治疗组不良反应发生率5.77% (3/52),对照组不良反应发生率9.62% (5/52),2组不良反应发生率比 较,差异无统计学意义(P>0.05)。治疗组疾病复发率16.33% (8/49),低于对照组40.48% (17/42)(P< 0.05)。结论:养血祛风方联合止痒方外洗治疗血液透析患者血虚风燥型皮肤瘙痒效果良好,能够减轻患者炎 症反应,提升生活质量,降低疾病复发率,安全性较高。

    Abstract:

    Abstract Objective: To observe the clinical effect of Yangxue Qufeng Prescription combined with Zhiyang Prescription for external washing in the treatment of skin itching of blood deficiency and wind-dryness type in hemodialysis patients. Methods: A total of 104 patients who had skin itching of blood deficiency and wind-dryness type, underwent hemodialysis, and were admitted to Wenling Hospital of Traditional Chinese Medicine from March 2023 to December 2023 were randomly divided into the treatment group and the control group,with 52 patients in each group. The control group was treated with Loratadine,while the treatment group was given a combination treatment of Yangxue Qufeng Prescription combined with Zhiyang Prescription for external washing on the basis of the control group. The two groups were treated continuously for four weeks. Traditional Chinese medicine(TCM) syndrome scores, modified Duo's itch scores, Dermatology Life Quality Index (DLQI) scores, and levels of inflammatory factors were compared between two groups before and after treatment; the clinical effects, incidence of adverse reactions, and disease recurrence rates were compared between the two groups. Results:The total effective rate in the treatment group was 94.23% (49/52),which was higher than that of 80.77% (42/52) in the control group (P<0.05). After treatment, the modified Duo's itch scores,TCM syndrome scores,DLQI scores,the levels of serum C-reactive protein (CRP), tumor necrosis factor-α (TNF-α),and interleukin-6 (IL-6) in the two groups were decreased when compared with those before treatment (P<0.05),and the modified Duo's itch scores,TCM syndrome scores,DLQI scores,and the levels of serum inflammatory factors in the treatment group were lower than those in the control group (P<0.05). The incidence of adverse reactions in the treatment group was 5.77% (3/52),while that in the control group was 9.62% (5/ 52), with no significance in the difference between the two groups (P>0.05). The recurrence rate in the treatment group was 16.33%( 8/49),which was lower than that of 40.48%( 17/42) in the control group( P<0.05). Conclusion: The combination of Yangxue Qufeng Prescription combined with Zhiyang Prescription for external washing is effective in treating skin itching of blood deficiency and wind-dryness type in hemodialysis patients. It can reduce inflammation responses,improve quality of life,reduce disease recurrence rate,and has higher safety.

    参考文献
    相似文献
    引证文献
引用本文

孔林英,邬莹莹.养血祛风方联合止痒方外洗治疗血液透析患者血虚风燥型皮肤瘙痒临床研究[J].新中医,2025,57(1):172-176

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-01-14
  • 出版日期:
文章二维码